抗肿瘤治疗引起急性口腔黏膜炎的诊断和防治专家共识

2021-05-15 中国临床肿瘤学会抗肿瘤药物安全管理专家委员会 临床肿瘤学杂志

口腔黏膜炎(oral mucositis,OM)是指口腔黏膜上皮炎症性和/或溃疡性病变,常见病因或诱因有病原微生物、免疫功能紊乱、理化损伤和某些药物等。

中文标题:

抗肿瘤治疗引起急性口腔黏膜炎的诊断和防治专家共识

发布日期:

2021-05-15

简要介绍:

口腔黏膜炎(oral mucositis,OM)是指口腔黏膜上皮炎症性和/或溃疡性病变,常见病因或诱因有病原微生物、免疫功能紊乱、理化损伤和某些药物等。对于恶性肿瘤患者实施放疗、化疗、分子靶向药物治疗或者免疫检查点抑制剂治疗等,是抗肿瘤治疗引起OM的主要原因[1-2]。OM常可致口腔疼痛难忍,不仅明显影响患者的进食、讲话及休息,还可能降低患者对于抗肿瘤治疗的耐受性和依从性,.

相关资料下载:
[AttachmentFileName(sort=1, fileName=抗肿瘤治疗引起急性口腔黏膜炎的诊断和防治专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=009e01c0022531ad, title=抗肿瘤治疗引起急性口腔黏膜炎的诊断和防治专家共识, enTitle=, guiderFrom=临床肿瘤学杂志, authorId=0, author=, summary=口腔黏膜炎(oral mucositis,OM)是指口腔黏膜上皮炎症性和/或溃疡性病变,常见病因或诱因有病原微生物、免疫功能紊乱、理化损伤和某些药物等。, cover=https://img.medsci.cn/2021114/1635955637821_1608702.jpg, journalId=0, articlesId=null, associationId=964, associationName=中国临床肿瘤学会抗肿瘤药物安全管理专家委员会, associationIntro=null, copyright=0, guiderPublishedTime=Sat May 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">口腔黏膜炎(oral mucositis,OM)是指口腔黏膜上皮炎症性和/或溃疡性病变,常见病因或诱因有病原微生物、免疫功能紊乱、理化损伤和某些药物等。对于恶性肿瘤患者实施放疗、化疗、分子靶向药物治疗或者免疫检查点抑制剂治疗等,是抗肿瘤治疗引起OM的主要原因</span><sup style="color: #333333;">[1-2]</sup><span style="color: #333333;">。OM常可致口腔疼痛难忍,不仅明显影响患者的进食、讲话及休息,还可能降低患者对于抗肿瘤治疗的耐受性和依从性,.</span></p>, tagList=[TagDto(tagId=63287, tagName=口腔黏膜炎)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=31, categoryName=口腔科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=63287, guiderKeyword=口腔黏膜炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5446, appHits=172, showAppHits=0, pcHits=544, showPcHits=5274, likes=3, shares=37, comments=8, approvalStatus=1, publishedTime=Tue Nov 16 23:56:36 CST 2021, publishedTimeString=2021-05-15, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Thu Nov 04 00:20:54 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Sat Jan 06 06:34:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=抗肿瘤治疗引起急性口腔黏膜炎的诊断和防治专家共识.pdf)])
抗肿瘤治疗引起急性口腔黏膜炎的诊断和防治专家共识.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2092457, encodeId=5b96209245ef9, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78f8353119, createdName=ms6000000074653151, createdTime=Sat Oct 08 11:10:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084991, encodeId=1ccb108499141, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da85646536, createdName=ms3000001955880154, createdTime=Tue Dec 28 07:48:34 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073424, encodeId=e3cd10e3424ba, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21d45722224, createdName=ms7000001942155623, createdTime=Wed Nov 24 09:04:47 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072600, encodeId=310d10e2600b5, content=新知识点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Sun Nov 21 19:54:16 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066812, encodeId=90fe10668128f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0aa2211235, createdName=120d6a47m86暂无昵称, createdTime=Thu Nov 04 08:29:03 CST 2021, time=2021-11-04, status=1, ipAttribution=)]
    2022-10-08 ms6000000074653151

    很实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2092457, encodeId=5b96209245ef9, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78f8353119, createdName=ms6000000074653151, createdTime=Sat Oct 08 11:10:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084991, encodeId=1ccb108499141, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da85646536, createdName=ms3000001955880154, createdTime=Tue Dec 28 07:48:34 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073424, encodeId=e3cd10e3424ba, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21d45722224, createdName=ms7000001942155623, createdTime=Wed Nov 24 09:04:47 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072600, encodeId=310d10e2600b5, content=新知识点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Sun Nov 21 19:54:16 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066812, encodeId=90fe10668128f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0aa2211235, createdName=120d6a47m86暂无昵称, createdTime=Thu Nov 04 08:29:03 CST 2021, time=2021-11-04, status=1, ipAttribution=)]
    2021-12-28 ms3000001955880154

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2092457, encodeId=5b96209245ef9, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78f8353119, createdName=ms6000000074653151, createdTime=Sat Oct 08 11:10:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084991, encodeId=1ccb108499141, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da85646536, createdName=ms3000001955880154, createdTime=Tue Dec 28 07:48:34 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073424, encodeId=e3cd10e3424ba, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21d45722224, createdName=ms7000001942155623, createdTime=Wed Nov 24 09:04:47 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072600, encodeId=310d10e2600b5, content=新知识点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Sun Nov 21 19:54:16 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066812, encodeId=90fe10668128f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0aa2211235, createdName=120d6a47m86暂无昵称, createdTime=Thu Nov 04 08:29:03 CST 2021, time=2021-11-04, status=1, ipAttribution=)]
    2021-11-24 ms7000001942155623

    谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2092457, encodeId=5b96209245ef9, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78f8353119, createdName=ms6000000074653151, createdTime=Sat Oct 08 11:10:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084991, encodeId=1ccb108499141, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da85646536, createdName=ms3000001955880154, createdTime=Tue Dec 28 07:48:34 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073424, encodeId=e3cd10e3424ba, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21d45722224, createdName=ms7000001942155623, createdTime=Wed Nov 24 09:04:47 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072600, encodeId=310d10e2600b5, content=新知识点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Sun Nov 21 19:54:16 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066812, encodeId=90fe10668128f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0aa2211235, createdName=120d6a47m86暂无昵称, createdTime=Thu Nov 04 08:29:03 CST 2021, time=2021-11-04, status=1, ipAttribution=)]
    2021-11-21 薛鹏

    新知识点

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2092457, encodeId=5b96209245ef9, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78f8353119, createdName=ms6000000074653151, createdTime=Sat Oct 08 11:10:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084991, encodeId=1ccb108499141, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da85646536, createdName=ms3000001955880154, createdTime=Tue Dec 28 07:48:34 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073424, encodeId=e3cd10e3424ba, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21d45722224, createdName=ms7000001942155623, createdTime=Wed Nov 24 09:04:47 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072600, encodeId=310d10e2600b5, content=新知识点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Sun Nov 21 19:54:16 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066812, encodeId=90fe10668128f, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0aa2211235, createdName=120d6a47m86暂无昵称, createdTime=Thu Nov 04 08:29:03 CST 2021, time=2021-11-04, status=1, ipAttribution=)]
    2021-11-04 120d6a47m86暂无昵称

    谢谢分享

    0

拓展阅读

中国癌症症状管理实践指南 ———口腔黏膜炎

中国抗癌协会肿瘤护理专业委员会 · 2020-10-01

成人造血干细胞移植后口腔黏膜炎护理最佳证据总结

深圳大学总医院护理部 · 2022-02-25

头颈癌放射性口腔黏膜炎病人营养管理方案的构建

浙江中医药大学护理学院 · 2024-01-23